Lysodren Tablet
Product Images NDC 76336-080

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lysodren (NDC 76336-080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hra Pharma Rare Diseases, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 Tablet Bottle Carton)

Packaging label for Lysodren 500 mg tablets, containing mitotane for oral use. The label shows the product strength (500 mg) and indicates the package contains 100 tablets. It includes handling instructions, storage conditions, and manufacturer information for Corden Pharma Latina S.p.A., Italy. The label is marked Rx only and features the HRA Pharma Rare Diseases logo.*

FDA Label Image

Image Mitotane Chemical Structure (Lysodren Struct)

Chemical structure of mitotane, showing a central carbon bonded to two chlorinated benzene rings and two chlorine atoms attached as substituents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.